Temat: "Metabolic diseases" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: ACE2 and energy metabolism: the connection between COVID-19 and chronic metabolic disorders.
Autorzy :: Cao X; Beijing Diabetes Institute, Beijing Key Laboratory of Diabetes Research and Care, Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
Song LN; Beijing Diabetes Institute, Beijing Key Laboratory of Diabetes Research and Care, Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
Yang JK; Beijing Diabetes Institute, Beijing Key Laboratory of Diabetes Research and Care, Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.; Pokaż więcej
Źródło :: Clinical science (London, England : 1979) [Clin Sci (Lond)] 2021 Feb 12; Vol. 135 (3), pp. 535-554.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Angiotensin-Converting Enzyme 2/*metabolism
COVID-19/*enzymology
Metabolic Diseases/*enzymology
Angiotensin-Converting Enzyme 2/genetics ; Animals ; COVID-19/genetics ; COVID-19/metabolism ; COVID-19/virology ; Energy Metabolism ; Humans ; Metabolic Diseases/genetics ; Metabolic Diseases/metabolism ; Metabolic Diseases/virology ; Peptidyl-Dipeptidase A/genetics ; Peptidyl-Dipeptidase A/metabolism ; Renin-Angiotensin System ; SARS-CoV-2/physiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: COVID-19 alters thinking and management in metabolic diseases.
Autorzy :: le Roux CW; Diabetes Complications Research Centre, Conway Institute, University College Dublin, Dublin, Ireland. .; Pokaż więcej
Źródło :: Nature reviews. Endocrinology [Nat Rev Endocrinol] 2021 Feb; Vol. 17 (2), pp. 71-72.
Typ publikacji :: Journal Article
MeSH Terms :: Delivery of Health Care*/methods
Delivery of Health Care*/organization & administration
Delivery of Health Care*/standards
COVID-19/*epidemiology
COVID-19/*therapy
Metabolic Diseases/*therapy
Respiration, Artificial/*methods
Air Pressure ; Autopsy ; Body Mass Index ; COVID-19/complications ; COVID-19/pathology ; Cause of Death ; Comorbidity ; Endothelium, Vascular/pathology ; Endothelium, Vascular/virology ; Humans ; Lung/blood supply ; Lung/pathology ; Lung/virology ; Metabolic Diseases/complications ; Metabolic Diseases/epidemiology ; Metabolic Diseases/pathology ; Neovascularization, Pathologic/mortality ; Neovascularization, Pathologic/pathology ; Neovascularization, Pathologic/virology ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/therapy ; Pulmonary Embolism/mortality ; Pulmonary Embolism/pathology ; Pulmonary Embolism/therapy ; Pulmonary Embolism/virology ; Respiration, Artificial/standards ; Respiratory Distress Syndrome/epidemiology ; Respiratory Distress Syndrome/pathology ; Respiratory Distress Syndrome/therapy ; Respiratory Distress Syndrome/virology ; Risk Factors ; SARS-CoV-2/physiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Role of MAIT cells in metabolic diseases.
Autorzy :: Toubal A; Université de Paris, Institut Cochin, INSERM U1016, CNRS UMR 8104, Paris, France. Electronic address: .
Lehuen A; Université de Paris, Institut Cochin, INSERM U1016, CNRS UMR 8104, Paris, France. Electronic address: .; Pokaż więcej
Źródło :: Molecular immunology [Mol Immunol] 2021 Feb; Vol. 130, pp. 142-147. Date of Electronic Publication: 2020 Dec 25.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :: Metabolic Diseases/*etiology
Mucosal-Associated Invariant T Cells/*physiology
Adipose Tissue/immunology ; Adipose Tissue/physiology ; Animals ; Humans ; Immunity, Mucosal/physiology ; Liver/immunology ; Liver/physiology ; Metabolic Diseases/immunology ; Metabolic Diseases/pathology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Congenital disorders of glycosylation - an umbrella term for rapidly expanding group of rare genetic metabolic disorders - importance of physical investigation.
Autorzy :: Lekka DE
Brucknerova J
Salingova A
Sebova C
Ostrozlikova M
Ziburova J
Nemcovic M
Sestak S
Bellova J
Pakanova Z
Sivakova B
Skoknova M
Bzduch V
Mucha J
Barath P
Brucknerova I; Pokaż więcej
Źródło :: Bratislavske lekarske listy [Bratisl Lek Listy] 2021; Vol. 122 (3), pp. 190-195.
Typ publikacji :: Case Reports; Journal Article
MeSH Terms :: Congenital Disorders of Glycosylation*/diagnosis
Congenital Disorders of Glycosylation*/genetics
Metabolic Diseases*/diagnosis
Metabolic Diseases*/genetics
Child ; Glycosylation ; Humans ; Infant, Newborn ; Mass Screening
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence.
Autorzy :: Xu X; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
Yi H; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
Wu J; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
Kuang T; School of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
Zhang J; School of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
Li Q; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
Du H; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
Xu T; School of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
Jiang G; School of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China. Electronic address: .
Fan G; School of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China. Electronic address: .; Pokaż więcej
Źródło :: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2021 Jan; Vol. 133, pp. 110984. Date of Electronic Publication: 2020 Nov 10.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Berberine/*therapeutic use
Energy Metabolism/*drug effects
Metabolic Diseases/*drug therapy
Animals ; Berberine/adverse effects ; Berberine/pharmacokinetics ; Biological Availability ; Humans ; Metabolic Diseases/metabolism ; Metabolic Diseases/physiopathology ; Signal Transduction ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Metabolic disease as a risk of hepatocellular carcinoma.
Autorzy :: Nishida N; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-sayama, Japan.; Pokaż więcej
Źródło :: Clinical and molecular hepatology [Clin Mol Hepatol] 2021 Jan; Vol. 27 (1), pp. 87-90. Date of Electronic Publication: 2020 Dec 03.
Typ publikacji :: Editorial; Comment
MeSH Terms :: Carcinoma, Hepatocellular*/diagnosis
Liver Neoplasms*/diagnosis
Metabolic Diseases*
Metabolic Syndrome*
Humans ; Obesity
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Therapeutic mechanisms of traditional Chinese medicine to improve metabolic diseases via the gut microbiota.
Autorzy :: Zhang HY; Department of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China; Graduate College, Beijing University of Traditional Chinese Medicine, Beijing, 100029, China.
Tian JX; Department of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China. Electronic address: .
Lian FM; Department of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
Li M; Department of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
Liu WK; Department of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
Zhen Z; Department of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
Liao JQ; Department of National Integrated Traditional and Western Medicine Center for Cardiovascular Disease, China-Japan Friendship Hospital, Beijing, 100029, China.
Tong XL; Department of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China. Electronic address: .; Pokaż więcej
Źródło :: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2021 Jan; Vol. 133, pp. 110857. Date of Electronic Publication: 2020 Nov 13.
Typ publikacji :: Journal Article; Systematic Review
MeSH Terms :: Medicine, Chinese Traditional*
Bacteria/*drug effects
Drugs, Chinese Herbal/*therapeutic use
Energy Metabolism/*drug effects
Gastrointestinal Microbiome/*drug effects
Intestines/*microbiology
Metabolic Diseases/*drug therapy
Animals ; Bacteria/metabolism ; Blood Glucose/metabolism ; Dysbiosis ; Humans ; Lipid Metabolism/drug effects ; Metabolic Diseases/metabolism ; Metabolic Diseases/microbiology ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Trained Immunity and Cardiometabolic Disease: The Role of Bone Marrow.
Autorzy :: Mitroulis I; Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Germany (I.M., T.C.).; National Center for Tumor Diseases (NCT), Partner Site Dresden, German Cancer Research Center (DKFZ), Heidelberg, Germany (I.M.).; First Department of Internal Medicine, Department of Haematology and Laboratory of Molecular Hematology, Democritus University of Thrace, Alexandroupolis, Greece (I.M.).
Hajishengallis G; Laboratory of Innate Immunity and Inflammation, Department of Basic and Translational Sciences, Penn Dental Medicine, University of Pennsylvania, Philadelphia (G.H.).
Chavakis T; Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Germany (I.M., T.C.).; Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, United Kingdom (T.C.).; Pokaż więcej
Źródło :: Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2021 Jan; Vol. 41 (1), pp. 48-54. Date of Electronic Publication: 2020 Nov 19.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms :: Immunity, Innate*
Immunologic Memory*
Bone Marrow/*immunology
Cardiovascular Diseases/*immunology
Hematopoietic Stem Cells/*immunology
Metabolic Diseases/*immunology
Bone Marrow/metabolism ; Bone Marrow/pathology ; Cardiovascular Diseases/metabolism ; Cardiovascular Diseases/pathology ; Hematopoietic Stem Cells/metabolism ; Hematopoietic Stem Cells/pathology ; Humans ; Metabolic Diseases/metabolism ; Metabolic Diseases/pathology ; Myelopoiesis
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: In vitro and in vivo uterine metabolic disorders induced by silica nanoparticle through the AMPK signaling pathway.
Autorzy :: Tian J; Key Laboratory of Birth Regulation and Control Technology of National Health Commission of China, Maternal and Child Health Care Hospital of Shandong Province, Shandong University, Jinan 250001, China; School of Public Health, Weifang Medical University, Weifang 261042, China.
Li J; Key Laboratory of Birth Regulation and Control Technology of National Health Commission of China, Maternal and Child Health Care Hospital of Shandong Province, Shandong University, Jinan 250001, China; School of Public Health, Weifang Medical University, Weifang 261042, China.
Yin H; Key Laboratory of Birth Regulation and Control Technology of National Health Commission of China, Maternal and Child Health Care Hospital of Shandong Province, Shandong University, Jinan 250001, China; School of Public Health, Weifang Medical University, Weifang 261042, China.
Ma L; Key Laboratory of Birth Regulation and Control Technology of National Health Commission of China, Maternal and Child Health Care Hospital of Shandong Province, Shandong University, Jinan 250001, China; School of Public Health, Weifang Medical University, Weifang 261042, China.
Zhang J; School of Public Health, North China University of Science and Technology, Tangshan 063000, China.
Zhai Q; School of Public Health, Weifang Medical University, Weifang 261042, China.
Duan S; Key Laboratory of Birth Regulation and Control Technology of National Health Commission of China, Maternal and Child Health Care Hospital of Shandong Province, Shandong University, Jinan 250001, China; School of Public Health, Zhengzhou University, Zhengzhou 450001, China. Electronic address: .
Zhang L; Key Laboratory of Birth Regulation and Control Technology of National Health Commission of China, Maternal and Child Health Care Hospital of Shandong Province, Shandong University, Jinan 250001, China. Electronic address: .; Pokaż więcej
Źródło :: The Science of the total environment [Sci Total Environ] 2021 Mar 25; Vol. 762, pp. 143152. Date of Electronic Publication: 2020 Oct 21.
Typ publikacji :: Journal Article
MeSH Terms :: Metabolic Diseases*
Nanoparticles*/toxicity
AMP-Activated Protein Kinases ; Animals ; Mice ; Signal Transduction ; Silicon Dioxide ; Tissue Distribution
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: [A case of PIK3R1 gene variation induced SHORT syndrome].
Autorzy :: Cao BY; Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.
Wu D; Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.
Gong CX; Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.; Pokaż więcej
Źródło :: Zhonghua er ke za zhi = Chinese journal of pediatrics [Zhonghua Er Ke Za Zhi] 2021 Mar 02; Vol. 59 (3), pp. 228-230.
Typ publikacji :: Case Reports; Journal Article
MeSH Terms :: Hypercalcemia*
Metabolic Diseases*
Nephrocalcinosis*
Class Ia Phosphatidylinositol 3-Kinase ; Growth Disorders ; Humans
SCR Disease Name :: SHORT syndrome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Developmental and Early Life Origins of Cardiometabolic Risk Factors: Novel Findings and Implications.
Autorzy :: Lurbe E; From the Pediatric Department, Consorcio Hospital General, University of Valencia (E.L.).; CIBER Fisiopatología Obesidad y Nutrición (CB06/03), Instituto de Salud Carlos III, Spain (E.L.).
Ingelfinger J; Department of Pediatrics, Harvard Medical School, Mass General Hospital for Children, Massachusetts General Hospital, Boston (J.I.).; Pokaż więcej
Źródło :: Hypertension (Dallas, Tex. : 1979) [Hypertension] 2021 Feb; Vol. 77 (2), pp. 308-318. Date of Electronic Publication: 2021 Jan 04.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :: Epigenesis, Genetic*
Cardiovascular Diseases/*etiology
Metabolic Diseases/*etiology
Adolescent ; Adult ; Adverse Childhood Experiences ; Aging ; Birth Weight ; Cardiovascular Diseases/embryology ; Cardiovascular System/growth & development ; Child ; Child, Preschool ; Epigenomics/methods ; Female ; Forecasting ; Gestational Age ; Humans ; Infant ; Infant, Low Birth Weight ; Infant, Newborn ; Infant, Premature ; Male ; Metabolic Diseases/embryology ; Metabolomics ; Microbiota ; Middle Aged ; Precision Medicine ; Pregnancy ; Prenatal Exposure Delayed Effects ; Proteomics ; Risk Factors
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: The circadian machinery links metabolic disorders and depression: A review of pathways, proteins and potential pharmacological interventions.
Autorzy :: Pitsillou E; Epigenomic Medicine, Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia; School of Science, College of Science, Engineering & Health, RMIT University, VIC 3001, Australia.
Liang J; Epigenomic Medicine, Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia; School of Science, College of Science, Engineering & Health, RMIT University, VIC 3001, Australia.
Hung A; School of Science, College of Science, Engineering & Health, RMIT University, VIC 3001, Australia.
Karagiannis TC; Epigenomic Medicine, Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia; Department of Clinical Pathology, The University of Melbourne, Parkville, VIC 3052, Australia. Electronic address: .; Pokaż więcej
Źródło :: Life sciences [Life Sci] 2021 Jan 15; Vol. 265, pp. 118809. Date of Electronic Publication: 2020 Nov 26.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Circadian Rhythm/*physiology
Depression/*physiopathology
Metabolic Diseases/*physiopathology
Animals ; Circadian Clocks/physiology ; Depression/drug therapy ; Humans ; Metabolic Diseases/drug therapy ; Signal Transduction/physiology ; Suprachiasmatic Nucleus/physiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Transgenerational metabolic disorders and reproduction defects induced by benzo[a]pyrene in Xenopus tropicalis.
Autorzy :: Usal M; Univ. Grenoble-Alpes, Univ. Savoie Mont Blanc, CNRS, LECA, 38000, Grenoble, France. Electronic address: .
Veyrenc S; Univ. Grenoble-Alpes, Univ. Savoie Mont Blanc, CNRS, LECA, 38000, Grenoble, France. Electronic address: .
Darracq-Ghitalla-Ciock M; Univ. Grenoble-Alpes, Univ. Savoie Mont Blanc, CNRS, LECA, 38000, Grenoble, France. Electronic address: .
Regnault C; Univ. Grenoble-Alpes, Univ. Savoie Mont Blanc, CNRS, LECA, 38000, Grenoble, France. Electronic address: .
Sroda S; Univ. Grenoble-Alpes, Univ. Savoie Mont Blanc, CNRS, LECA, 38000, Grenoble, France. Electronic address: .
Fini JB; Unité PhyMA Laboratory, Adaptation Du Vivant, Muséum National D'Histoire Naturelle, 7 Rue Cuvier, 75005, Paris, France. Electronic address: .
Canlet C; Toxalim-Research Centre in Food Toxicology, Toulouse University, INRAE UMR 1331, ENVT, INP-Purpan, Paul Sabatier University, F-31027, Toulouse, France; Metatoul-AXIOM Platform, National Infrastructure for Metabolomics and Fluxomics, MetaboHUB, Toxalim, INRAE UMR 1331, F-31027, Toulouse, France. Electronic address: .
Tremblay-Franco M; Toxalim-Research Centre in Food Toxicology, Toulouse University, INRAE UMR 1331, ENVT, INP-Purpan, Paul Sabatier University, F-31027, Toulouse, France; Metatoul-AXIOM Platform, National Infrastructure for Metabolomics and Fluxomics, MetaboHUB, Toxalim, INRAE UMR 1331, F-31027, Toulouse, France. Electronic address: .
Raveton M; Univ. Grenoble-Alpes, Univ. Savoie Mont Blanc, CNRS, LECA, 38000, Grenoble, France. Electronic address: .
Reynaud S; Univ. Grenoble-Alpes, Univ. Savoie Mont Blanc, CNRS, LECA, 38000, Grenoble, France. Electronic address: .; Pokaż więcej
Źródło :: Environmental pollution (Barking, Essex : 1987) [Environ Pollut] 2021 Jan 15; Vol. 269, pp. 116109. Date of Electronic Publication: 2020 Nov 18.
Typ publikacji :: Journal Article
MeSH Terms :: Endocrine Disruptors*
Metabolic Diseases*/chemically induced
Animals ; Benzo(a)pyrene/toxicity ; Female ; Humans ; Reproduction ; Xenopus
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Nonconserved Long Intergenic Noncoding RNAs Associate With Complex Cardiometabolic Disease Traits.
Autorzy :: Foulkes AS; Biostatistics Center, Massachusetts General Hospital, Boston (A.S.F., C.S., T.C.).; Department of Medicine, Harvard Medical School, Boston, MA (A.S.F.).; Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA (A.S.F., T.C.).
Selvaggi C; Biostatistics Center, Massachusetts General Hospital, Boston (A.S.F., C.S., T.C.).
Cao T; Biostatistics Center, Massachusetts General Hospital, Boston (A.S.F., C.S., T.C.).; Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA (A.S.F., T.C.).
O'Reilly ME; Cardiology Division, Department of Medicine (M.E.O., E.C., H.L., C.X., M.P.R.), Columbia University, New York, NY.
Cynn E; Cardiology Division, Department of Medicine (M.E.O., E.C., H.L., C.X., M.P.R.), Columbia University, New York, NY.
Ma P; Data Science Institute, Stanford University, CA (P.M.).
Lumish H; Cardiology Division, Department of Medicine (M.E.O., E.C., H.L., C.X., M.P.R.), Columbia University, New York, NY.
Xue C; Cardiology Division, Department of Medicine (M.E.O., E.C., H.L., C.X., M.P.R.), Columbia University, New York, NY.
Reilly MP; Cardiology Division, Department of Medicine (M.E.O., E.C., H.L., C.X., M.P.R.), Columbia University, New York, NY.; Irving Institute for Clinical and Translational Sciences (M.P.R.), Columbia University, New York, NY.; Pokaż więcej
Źródło :: Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2021 Jan; Vol. 41 (1), pp. 501-511. Date of Electronic Publication: 2020 Nov 12.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :: Multifactorial Inheritance*
Polymorphism, Single Nucleotide*
Synteny*
Cardiovascular Diseases/*genetics
Metabolic Diseases/*genetics
RNA, Long Noncoding/*genetics
Cardiometabolic Risk Factors ; Cardiovascular Diseases/diagnosis ; Databases, Genetic ; Genetic Predisposition to Disease ; Genome-Wide Association Study ; Heredity ; Humans ; Metabolic Diseases/diagnosis ; Pedigree ; Risk Assessment
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Reduction in the incidence of infectious diseases during the COVID-19 pandemic: A hypothesis.
Autorzy :: MohammadSadeghi A; School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: .; Pokaż więcej
Źródło :: Medical hypotheses [Med Hypotheses] 2021 Jan; Vol. 146, pp. 110465. Date of Electronic Publication: 2020 Dec 22.
Typ publikacji :: Letter; Comment
MeSH Terms :: COVID-19*
Communicable Diseases*/epidemiology
Metabolic Diseases*
Humans ; Incidence ; Life Style ; Pandemics/prevention & control ; SARS-CoV-2
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: COVID-19 changes the lifestyle of the population and subtly reduces the incidence of metabolic disease.
Autorzy :: Yu X; Southeast University, China. Electronic address: .; Pokaż więcej
Źródło :: Medical hypotheses [Med Hypotheses] 2021 Jan; Vol. 146, pp. 110416. Date of Electronic Publication: 2020 Nov 25.
Typ publikacji :: Letter
MeSH Terms :: Life Style*
Pandemics*
SARS-CoV-2*
COVID-19/*epidemiology
Metabolic Diseases/*prevention & control
COVID-19/psychology ; China/epidemiology ; Exercise ; Feeding Behavior ; Humans ; Incidence ; Metabolic Diseases/epidemiology ; Nutritional Status ; Risk Factors
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Redefining fatty liver disease: an international patient perspective.
Autorzy :: Shiha G; European Liver Patients' Association (ELPA), Brussels, Belgium; World Hepatitis Alliance, London, UK; African Liver Patient Association (ALPA), Cairo, Egypt; Association of Liver Patients Care (ALPC), Mansoura, Egypt; Hepatology and Gastroenterology Unit, Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt; Egyptian Liver Research Institute and Hospital (ELRIAH), Mansoura, Egypt. Electronic address: .
Korenjak M; European Liver Patients' Association (ELPA), Brussels, Belgium; Association SLOVENIA HEP, Maribor, Slovenia.
Eskridge W; Fatty Liver Foundation, Boise, ID, USA.
Casanovas T; European Liver Patients' Association (ELPA), Brussels, Belgium; Asociación Catalana de Pacientes Hepáticos (ASSCAT), Barcelona, Spain.
Velez-Moller P; World Hepatitis Alliance, London, UK; Guatemala Liver Patients Association, Guatemala City, Guatemala.
Högström S; European Liver Patients' Association (ELPA), Brussels, Belgium; Finnish Kidney and Liver Association, Helsinki, Finland.
Richardson B; The Liver Foundation, Woolloongabba, QLD, Australia.
Munoz C; Yellow Warriors Society Philippines (YWSP), Manila, Philippines.
Sigurðardóttir S; The European Coalition for People Living with Obesity (EASO ECPO), Dublin, Ireland.
Coulibaly A; World Hepatitis Alliance, London, UK; African Liver Patient Association (ALPA), Cairo, Egypt; Association for the Promotion of Health and Development in Mali (APSAD/MALI), Bamako, Mali; Association of the Malians of Washington DC (AMAW), Washington DC, USA.
Milan M; European Liver Patients' Association (ELPA), Brussels, Belgium; Hepar Centar, Bitola, North Macedonia.
Bautista F; Fundación Sayani, Jujuy, Argentina.
Leung NWY; ASIAHEP Hong Kong, Hong Kong Special Administrative Region, China.
Mooney V; The European Coalition for People Living with Obesity (EASO ECPO), Dublin, Ireland.
Obekpa S; African Liver Patient Association (ALPA), Cairo, Egypt; Advocacy for the Prevention of Hepatitis in Nigeria (APHIN), Benue State, Nigeria.
Bech E; La Federación Nacional de Enfermos y Trasplantados Hepáticos (FNETH), Madrid, Spain.
Polavarapu N; Save the Liver Foundation, Hyderabad, India.
Hamed AE; Arabic Association for the Study of Diabetes and Metabolism, Cairo, Egypt; Department of Internal Medicine, Hepatology, and Diabetes, Egyptian Military Medical Academy, Cairo, Egypt.
Radiani T; European Liver Patients' Association (ELPA), Brussels, Belgium; Hepatitis C Cured Patient Association, Tbilisi, Georgia.
Purwanto E; Budi Lukmanto Foundation, North Jakarta, Indonesia.
Bright B; Live Well Initiative (LWI), Lagos, Nigeria.
Ali M; National Liver Foundation of Bangladesh, Dhaka, Bangladesh.
Dovia CK; World Hepatitis Alliance, London, UK; African Liver Patient Association (ALPA), Cairo, Egypt; Cedaku Foundation of Ghana, Ho, Ghana.
McColaugh L; Leverforeningen, Odense C, Denmark.
Koulla Y; Cyprus Liver Patients Association, Nicosia, Cyprus.
Dufour JF; Swiss NASH Foundation, Bern, Switzerland; University Clinic for Visceral Surgery and Medicine, Inselspital, Bern, Switzerland; Department of Biomedical Research, University of Bern, Bern, Switzerland.
Soliman R; European Liver Patients' Association (ELPA), Brussels, Belgium; Association of Liver Patients Care (ALPC), Mansoura, Egypt; Egyptian Liver Research Institute and Hospital (ELRIAH), Mansoura, Egypt; Department of Tropical Medicine, Faculty of Medicine, Port Said University, Port Said, Egypt.
Eslam M; Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Westmead, NSW, Australia. Electronic address: .; Pokaż więcej
Źródło :: The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2021 Jan; Vol. 6 (1), pp. 73-79. Date of Electronic Publication: 2020 Oct 05.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Metabolic Diseases*
Non-alcoholic Fatty Liver Disease*/diagnosis
Non-alcoholic Fatty Liver Disease*/epidemiology
Non-alcoholic Fatty Liver Disease*/metabolism
Patient Care Management*/methods
Patient Care Management*/standards
Global Health ; Humans ; Quality Improvement ; Terminology as Topic
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Coadministration of metformin prevents olanzapine-induced metabolic dysfunction and regulates the gut-liver axis in rats.
Autorzy :: Luo C; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008, People's Republic of China.; Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha, 410078, People's Republic of China.; School of Life Sciences, Central South University, Changsha, 410078, Hunan, China.
Wang X; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008, People's Republic of China.; Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha, 410078, People's Republic of China.
Huang HX; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008, People's Republic of China.; Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha, 410078, People's Republic of China.
Mao XY; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008, People's Republic of China.; Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha, 410078, People's Republic of China.
Zhou HH; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008, People's Republic of China.; Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha, 410078, People's Republic of China.
Liu ZQ; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008, People's Republic of China. .; Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha, 410078, People's Republic of China. .; Pokaż więcej
Źródło :: Psychopharmacology [Psychopharmacology (Berl)] 2021 Jan; Vol. 238 (1), pp. 239-248. Date of Electronic Publication: 2020 Oct 23.
Typ publikacji :: Journal Article
MeSH Terms :: Adjuvants, Pharmaceutic/*pharmacology
Gastrointestinal Microbiome/*drug effects
Liver/*drug effects
Metabolic Diseases/*prevention & control
Metformin/*pharmacology
Olanzapine/*adverse effects
Adjuvants, Pharmaceutic/administration & dosage ; Animals ; Bacteroides/isolation & purification ; Blood Glucose/metabolism ; Body Weight/drug effects ; Dose-Response Relationship, Drug ; Feces/microbiology ; Humans ; Lactobacillus gasseri/isolation & purification ; Liver/metabolism ; Male ; Metabolic Diseases/chemically induced ; Metformin/administration & dosage ; Olanzapine/administration & dosage ; RNA, Ribosomal, 16S/genetics ; Rats
SCR Organism :: Bacteroides acidifaciens
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Clinical Presentation, Genetic Etiology, and Coenzyme Q10 Levels in 55 Children with Combined Enzyme Deficiencies of the Mitochondrial Respiratory Chain.
Autorzy :: Naess K; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, Stockholm, Sweden; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden. Electronic address: .
Bruhn H; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, Stockholm, Sweden; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Stranneheim H; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, Stockholm, Sweden; Department of Molecular Medicine and Surgery, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.
Freyer C; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, Stockholm, Sweden; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Wibom R; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, Stockholm, Sweden; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Mourier A; CNRS UMR 5095, Bordeaux Cedex, France; University of Bordeaux, EPST, IBGC UMR 5095, Bordeaux Cedex, France.
Engvall M; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, Stockholm, Sweden; Department of Molecular Medicine and Surgery, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.
Nennesmo I; Clinical Pathology, Karolinska University Hospital, Department of Laboratory Medicine, Stockholm, Sweden.
Lesko N; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, Stockholm, Sweden; Department of Molecular Medicine and Surgery, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.
Wredenberg A; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, Stockholm, Sweden; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Wedell A; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, Stockholm, Sweden; Department of Molecular Medicine and Surgery, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.
von Döbeln U; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, Stockholm, Sweden; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.; Pokaż więcej
Źródło :: The Journal of pediatrics [J Pediatr] 2021 Jan; Vol. 228, pp. 240-251.e2. Date of Electronic Publication: 2020 Aug 19.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Mutation*
DNA, Mitochondrial/*genetics
Metabolic Diseases/*genetics
Mitochondrial Diseases/*genetics
Ubiquinone/*analogs & derivatives
Adolescent ; Adult ; Child ; Child, Preschool ; DNA Mutational Analysis ; Humans ; Infant ; Infant, Newborn ; Metabolic Diseases/enzymology ; Mitochondrial Diseases/enzymology ; Ubiquinone/blood ; Whole Exome Sequencing ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Emerging Roles of Cannabinoids and Synthetic Cannabinoids in Clinical Experimental Models.
Autorzy :: Morales P; University of North Carolina, Greensboro, NC, USA.
Reggio PH; University of North Carolina, Greensboro, NC, USA.; Pokaż więcej
Źródło :: Advances in experimental medicine and biology [Adv Exp Med Biol] 2021; Vol. 1264, pp. 47-65.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Cannabinoids/*chemical synthesis
Cannabinoids/*therapeutic use
Metabolic Diseases/*drug therapy
Neoplasms/*drug therapy
Nervous System Diseases/*drug therapy
Cannabinoids/metabolism ; Endocannabinoids/metabolism ; Humans ; Metabolic Diseases/metabolism ; Models, Biological ; Neoplasms/metabolism ; Nervous System Diseases/metabolism
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Metabolic diseases"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język